Thalidomide as an anti-TNF-alpha inhibitor: implications for clinical use.
Klausner
J D
JD
Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York 10021-6399, USA.
Freedman
V H
VH
Kaplan
G
G
D000818:Animals; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D013792:Thalidomide / Q000494:pharmacology* / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D013792:Thalidomide